Papers: 10.1371/journal.pone.0237248

https://doi.org/10.1371/journal.pone.0237248

Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer

Cited by: 11
Author(s): Holger H.H. Erb, Julia Bodenbender, Florian Handle, Tamara Diehl, Lukas Donix, Igor Tsaur, Martin Gleave, Axel Haferkamp, Johannes Huber, Susanne Fuessel, Eva Juengel, Zoran Čulig, Christian Thomas
Published: about 6 years ago

Software Mentions 2